PERFUSION SYSTEMS CARDIOBLATE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING
|
Back to Search Results |
|
Model Number 49321 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Arrhythmia (1721)
|
Event Date 11/20/2022 |
Event Type
Injury
|
Event Description
|
The patient had a concomitant surgical procedure of mitral valve repair through sternotomy on (b)(6) 2022.On the day of the procedure a cyroflex probe powered by a cryoconsole, and a cardioblate bp2 clamp powered by an ft-10 generator were used.The left atrial appendage was successfully amputated/excised and oversewn.Left pulmonary vein (lpv) block was achieved.Right pulmonary vein (rpv) conduction block was achieved.On (b)(6) 2022 the patient experienced pauses.The patient had 2 back to back pauses totaling 6.8 seconds, noted on the non-medtronic patch provider prescribed.The on call physician was alerted to this and called the subject.The subject was asymptomatic and sleeping at time of event.Subject was advised to go back and resume what they were doing prior.The patient status was recovering/ resolving.The adverse event was deemed by the site as possibly related to the concomitant procedure and the study procedure and possibly related to the cardioblate bp2 clamp.The adverse event was deemed by the sponsor as causally related to the concomitant procedure and the study procedure and not related to the study devices.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|